| 1/3 | US=66 / Biol/Mol Hiyama E, Hiyama H. Diagnostic value I: solid tumors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 181-210. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. TUMORES SOLIDOS; TELOMERASE; TRANSCRIPTASE REVERSA HUMANA TELOMERASE; TERT; ASPIRATIVA POR AGULHA FINA; CITOLOGIA; PROTOCOLO DE AMPLIFICACAO TELOMERICA REPETICAO; TRAP; DIAGNOSTICO; PROGNOSTICO; HIBRIDIZACAO IN SITU; ISH; IMUNO-HISTOQUIMICA; IHC |
| 2/3 | US=66 / Biol/Mol Hiyama E. Protocol I: telomerase activity and telomerase expression. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 315-35. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0. PROTOCOLO I; ATIVIDADE DA TELOMERASE; EXPRESSAO DA TELOMERASE; TRAP; TELOMERASE; TERT; TERC; TECNICAS DE DETECCAO IN SITU |
| 3/3 | US=11 / Transplante Torlakovic EE, Naresh KN, Brunning RD. Other common markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 153-236. ISBN 978-0891895725. TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; MIELOPEROXIDASE; HEMOGLOBINA A; HGBA; TRIPTASE DE MASTOCITOS; DESOXINUCLEOTIDIL TRANSFERASE TERMINAL; TDT; ANTIGENO RELACIONADO AO FATOR 8; FATOR DE VON WILLEBRAND; PAX-5; PU.1; FLI-1; CICLINA D1; LISOZIMA; BCL-6; IMUNOGLOBINAS; KI-67; MOLECULAS CITOTOXICAS; MARCADORES DE ESTROMA; MUM1; TRAP; BCL-2 |